GERMANY: SCHERING IN CONTRAST AGENT DEAL
Article Abstract:
Schering AG is taking a stake worth US$ 20mn in Epix Medical Inc. of Cambridge, Massachusetts, and paying another US$ 30mn for the further development and marketing rights of MS-325, a NMR contrast agent for cardiovascular imaging. The rights cover all countries except for Japan. Moreover, the German company has secured rights to a further cardiovascular contrast agent of Epix. On the other hand, Epix gets an option for the further development and co-marketing of two products under development at Schering. MS-325, which is in phase III clinical trials, will be produced by Mallinckrodt Inc.
Publication Name: Chemische Rundschau
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0009-2983
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
GERMANY/US: GRAPHICAL FILMS BY NESCHEN, GBC
Article Abstract:
Neschen AG of Buckeberg
Publication Name: Chemische Rundschau
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0009-2983
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
GERMANY/SWITZERLAND: WAGNER AUTOMOBIL TO EMS
Article Abstract:
J. Wagner GmbH of Markdorf, Germany, has sold its Wagner Automobilsysteme division to Ems-Chemie Holding AG of Switzerland with effect from 1 February 2001. The German unit will be integrated with Eftec Europa Holding AG of Zug, Switzerland, a systems supplier for gluing, protection and sealing in the automotive sector.
Publication Name: Chemische Rundschau
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0009-2983
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: GERMANY: CAPITAL INJECTION TO VIROFEM. GERMANY: CANCER VACCINE TO UNDERGO TRIALS. GERMANY: CANCER DIAGNOSTICS R&D BY ADNAGEN
- Abstracts: GERMANY: ATRIX CANCER DRUG BY MEDIGENE. SWITZERLAND: EUROPEAN HEADQUARTERS FOR SUGEN. SWITZERLAND/US: ROCHE, OSI IN CANCER R&D DEAL
- Abstracts: GERMANY: SUSTAINABLE TECHNOLOGIES R&D BY HENKEL. GERMANY: CHEMETALL POLYMER ADDITIVES SOLD. GERMANY: NEW E-COMMERCE SITE FOR CHEMICALS
- Abstracts: US/SWITZERLAND: ZELLER COOPERATES WITH SKB. SWITZERLAND/JAPAN: NATURAL COSMETICS BY WELEDA